BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3111475)

  • 1. Inactivation of bee venom phospholipase A2 by manoalide. A model based on the reactivity of manoalide with amino acids and peptide sequences.
    Glaser KB; Jacobs RS
    Biochem Pharmacol; 1987 Jul; 36(13):2079-86. PubMed ID: 3111475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of phospholipase A2 by manoalide. Localization of the manoalide binding site on bee venom phospholipase A2.
    Glaser KB; Vedvick TS; Jacobs RS
    Biochem Pharmacol; 1988 Oct; 37(19):3639-46. PubMed ID: 3178877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of manoalide on secreted and intracellular phospholipases.
    Bennett CF; Mong S; Clarke MA; Kruse LI; Crooke ST
    Biochem Pharmacol; 1987 Mar; 36(5):733-40. PubMed ID: 3103628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pharmacology of manoalide. Inactivation of bee venom phospholipase A2.
    Glaser KB; Jacobs RS
    Biochem Pharmacol; 1986 Feb; 35(3):449-53. PubMed ID: 3947381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of venom phospholipases A2 by manoalide and manoalogue. Stoichiometry of incorporation.
    Reynolds LJ; Mihelich ED; Dennis EA
    J Biol Chem; 1991 Sep; 266(25):16512-7. PubMed ID: 1885583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
    Glaser KB; de Carvalho MS; Jacobs RS; Kernan MR; Faulkner DJ
    Mol Pharmacol; 1989 Nov; 36(5):782-8. PubMed ID: 2586492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of two specific lysines responsible for the inhibition of phospholipase A2 by manoalide.
    Bianco ID; Kelley MJ; Crowl RM; Dennis EA
    Biochim Biophys Acta; 1995 Jul; 1250(2):197-203. PubMed ID: 7632725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of human synovial fluid phospholipase A2 by the marine natural product, manoalide.
    Jacobson PB; Marshall LA; Sung A; Jacobs RS
    Biochem Pharmacol; 1990 May; 39(10):1557-64. PubMed ID: 2337412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular model of the interaction of bee venom phospholipase A2 with manoalide.
    Ortiz AR; Pisabarro MT; Gago F
    J Med Chem; 1993 Jun; 36(13):1866-79. PubMed ID: 8515424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cobra venom phospholipase A2 inhibition by manoalide. A novel type of phospholipase inhibitor.
    Lombardo D; Dennis EA
    J Biol Chem; 1985 Jun; 260(12):7234-40. PubMed ID: 3997864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of phospholipase A2 by manoalide and manoalide analogues.
    Deems RA; Lombardo D; Morgan BP; Mihelich ED; Dennis EA
    Biochim Biophys Acta; 1987 Feb; 917(2):258-68. PubMed ID: 3801502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-step inactivation of bee venom phospholipase A2 by scalaradial.
    de Carvalho MS; Jacobs RS
    Biochem Pharmacol; 1991 Sep; 42(8):1621-6. PubMed ID: 1930288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical modification and inactivation of phospholipases A2 by a manoalide analogue.
    Fujii S; Tahara Y; Toyomoto M; Hada S; Nishimura H; Inoue S; Ikeda K; Inagaki Y; Katsumura S; Samejima Y
    Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):297-304. PubMed ID: 7755577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of two phospholipase A2 inhibitors on the neuromuscular blocking activities of homologous phospholipases A2 from the venom of Pseudechis australis, the Australian king brown snake.
    Fatehi M; Rowan EG; Harvey AL
    Toxicon; 1995 Dec; 33(12):1633-43. PubMed ID: 8866620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activities.
    Hope WC; Patel BJ; Bolin DR
    Agents Actions; 1991 Sep; 34(1-2):77-80. PubMed ID: 1793057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of CD11b/CD18 expression in human neutrophils by phospholipase A2.
    Jacobson PB; Schrier DJ
    J Immunol; 1993 Nov; 151(10):5639-52. PubMed ID: 8228253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manoalide.
    Soriente A; De Rosa MM; Scettri A; Sodano G; Terencio MC; PayĆ” M; Alcaraz MJ
    Curr Med Chem; 1999 May; 6(5):415-31. PubMed ID: 10101221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of eicosanoid biosynthesis in vitro and in vivo by the marine natural product manoalide: a potent inactivator of venom phospholipases.
    Mayer AM; Glaser KB; Jacobs RS
    J Pharmacol Exp Ther; 1988 Mar; 244(3):871-8. PubMed ID: 3150849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the phospholipase A2 inhibitor, manoalide, on cartilage degradation, stromelysin expression, and synovial fluid cell count induced by intraarticular injection of human recombinant interleukin-1 alpha in the rabbit.
    Schrier DJ; Flory CM; Finkel M; Kuchera SL; Lesch ME; Jacobson PB
    Arthritis Rheum; 1996 Aug; 39(8):1292-9. PubMed ID: 8702436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Manoalide: a new phospholipase A2 inhibitor of marine origin with potential immunoregulatory effect].
    Mayer AM
    Medicina (B Aires); 1989; 49(2):175-80. PubMed ID: 2640487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.